Results 211 to 220 of about 794,896 (338)

The Link Between R&D Subsidies, R&D Spending and Technological Performance [PDF]

open access: yes
This paper analyzes the effects of public R&D funding on R&D expenditure and patenting behavior of German firms. The main focus is the direct impact of subsidies on R&D and the indirect effect on innovation output measured by patent applications.
Czarnitzki, Dirk, Hussinger, Katrin
core  

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

open access: yesMolecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto   +13 more
wiley   +1 more source

A Critical Analysis of the Proposed National Patent Board

open access: green, 1998
Richard P. Cusick   +3 more
openalex   +1 more source

IN SEARCH OF THE PRIVATELY OPTIMAL PATENT BREADTH [PDF]

open access: yes
Innovating firms choose to patent their innovations when patenting allows the appropriation of more rents than do other forms of intellectual property protection (e.g., trade secrecy).
Fulton, Murray E., Yiannaka, Amalia
core   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

open access: yesMolecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra   +10 more
wiley   +1 more source

The development of synthetic biology: a patent analysis. [PDF]

open access: yesSyst Synth Biol, 2013
van Doren D, Koenigstein S, Reiss T.
europepmc   +1 more source

Home - About - Disclaimer - Privacy